JIR
DVAX

James Investment Research’s Dynavax Technologies DVAX Stock Holding History

James Investment Research’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-82,924
Closed -$1.28M – 368
2025
Q4 		$1.28M Buy
82,924
+371
+0.4% +$4.09K 0.14% 135
2025
Q3 		$820K Buy
82,553
+15,425
+23% +$161K 0.09% 182
2025
Q2 		$666K Hold
67,128
– – 0.08% 187
2025
Q1 		$871K Hold
67,128
– – 0.11% 163
2024
Q4 		$857K Sell
67,128
-6
-0% -$73 0.1% 168
2024
Q3 		$748K Buy
67,134
+8,304
+14% +$91.5K 0.09% 184
2024
Q2 		$661K Sell
58,830
-24
-0% -$279 0.08% 192
2024
Q1 		$730K Buy
58,854
+11,764
+25% +$153K 0.09% 176
2023
Q4 		$658K Hold
47,090
– – 0.08% 177
2023
Q3 		$696K Buy
47,090
+5,855
+14% +$82.3K 0.09% 161
2023
Q2 		$533K Hold
41,235
– – 0.07% 184
2023
Q1 		$405K Hold
41,235
– – 0.05% 206
2022
Q4 		$439K Buy
41,235
+26,545
+181% +$308K 0.06% 184
2022
Q3 		$153K Buy
+14,690
New +$191K 0.02% 283

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

James Investment Research's DVAX Position: Q1 2026 in Review

James Investment Research sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 82,924 shares — an estimated $1.28M sold.

James Investment Research first reported a position in DVAX in Q3 2022 and held it in 14 quarters. The position peaked at $1.28M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • James Investment Research reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • James Investment Research sold 82,924 Dynavax Technologies shares in Q1 2026, an estimated $1.28M.
  • James Investment Research first reported a position in Dynavax Technologies in Q3 2022 and held it in 14 quarters.
  • James Investment Research's Dynavax Technologies position peaked at $1.28M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on James Investment Research's 13F filing for Q1 2026, filed 24 Apr 2026.